JP Morgan Chase & Co’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.9M | Sell |
|
|||||
|
2025
Q2 | $9.06M | Buy |
|
|||||
|
2025
Q1 | $1.28M | Buy |
|
|||||
|
2024
Q4 | $1.49M | Sell |
|
|||||
|
2024
Q3 | $6.65M | Buy |
|
|||||
|
2024
Q2 | $1.34M | Sell |
|
|||||
|
2024
Q1 | $18.3M | Sell |
|
|||||
|
2023
Q4 | $13M | Sell |
|
|||||
|
2023
Q3 | $8.65M | Sell |
|
|||||
|
2023
Q2 | $15.1M | Buy |
|
|||||
|
2023
Q1 | $16.8M | Buy |
|
|||||
|
2022
Q4 | $13.8M | Sell |
|
|||||
|
2022
Q3 | $12.2M | Sell |
|
|||||
|
2022
Q2 | $11.9M | Buy |
|
|||||
|
2022
Q1 | $6.92M | Sell |
|
|||||
|
2021
Q4 | $11.5M | Buy |
|
|||||
|
2021
Q3 | $9.75M | Buy |
|
|||||
|
2021
Q2 | $7.97M | Buy |
|
|||||
|
2021
Q1 | $2.29M | Buy |
|
|||||
|
2020
Q4 | $1.37M | Buy |
|